Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0369 | ||||
Gene Name | SLC45A2 | ||||
Protein Name | Membrane-associated transporter protein | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
Synonyms | 1A1; AIM1; MATP; Melanoma antigen AIM1; OCA4; Protein AIM-1; SHEP5; SLC45A2; Solute carrier family 45 member 2 | ||||
DT Family | Glycoside-Pentoside-Hexuronide (GPH):Cation Symporter Family ; | ||||
Tissue Specificity | Expressed in most melanoma cell lines andmelanocytes. | ||||
Function | This tranporter may meditates the transport of substances required for melanin biosynthesis. | ||||
Endogenous Substrate(s) | Sucrose | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(α) Genetic Polymorphisms of This DT |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
Sucrose
|
Phase 4 | Drug Info | Retinopathy of prematurity | 9B71.3 | [1] |
References | |||||
1 | Identification of amino acids important for substrate specificity in sucrose transporters using gene shuffling. J Biol Chem. 2012 Aug 31;287(36):30296-304. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.